Atlas Trials

The Pharmacokinetics and Cardiac Properties of Elacytarabine (CP-4055)

Clinical trial NCT01258816 · COMPLETED

Trial details

NCT number
NCT01258816
Sponsor
Clavis Pharma
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Relapsed/Refractory AML
Start date
2010-10-01
Primary completion
2013-05-01
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.